Programmed death ligand 1 (PD-L1) as an immunotherapy target in patients with glioblastoma

類似資料

• Increased expression of programmed death ligand 1 (PD-L1) in human pituitary tumors
  著者:: Mei, Yu, 等
  出版事項: (2016)
• Structural basis for small molecule targeting of the programmed death ligand 1 (PD-L1)
  著者:: Zak, Krzysztof M., 等
  出版事項: (2016)
• Nivolumab as Programmed Death-1 (PD-1) Inhibitor for Targeted Immunotherapy in Tumor
  著者:: Guo, Liting, 等
  出版事項: (2017)
• Programmed Death Ligand 1 (PD-L1) Expression in Primary Angiosarcoma
  著者:: Botti, Gerardo, 等
  出版事項: (2017)
• Fragment-based screening of programmed death ligand 1 (PD-L1)
  著者:: Perry, Evan, 等
  出版事項: (2019)